NASDAQ Companies

CHICAGO, Feb. 14, 2024 (GLOBE NEWSWIRE) — GCM Grosvenor (Nasdaq: GCMG), a global alternative asset management solutions provider, announced today […]

Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) […]

MUNICH, Germany, Feb. 14, 2024 (GLOBE NEWSWIRE) — Lilium N.V. (“Lilium” or the “Company”) (NASDAQ: LILM) today announced that it […]

IRVINE, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced […]

NEW YORK, Feb. 14, 2024 (GLOBE NEWSWIRE) — The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), […]

Company announces preliminary fourth-quarter 2023 revenue record in excess of $42 million, as well as a record-breaking full-year 2023 revenue […]

Fourth quarter revenues of $56.6 million, in line with previous guidance Fourth quarter GAAP net loss of $22.9 million; non-GAAP […]

Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase […]

SOLANA BEACH, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments […]

CAMBRIDGE, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on […]